News & Updates

Treatment with odevixibat led to rapid and sustained improvements in pruritus and serum bile acid (sBA) levels among patients with Alagille syndrome (ALGS), according to the final data of the phase III ASSERT-extension (ASSERT-EXT) study presented at The Liver Meeting 2024.

Endoscopists may unintentionally play down the risks of antiplatelet-related postendoscopic retrograde cholangiopancreatography (ERCP) bleeding (CSPEB) based on observations of suboptimal holding before higher risk ERCP, reports a study.

Researchers at the Chinese University of Hong Kong (CUHK) have developed a microbiome-based noninvasive diagnostic tool for inflammatory bowel disease (IBD), which received a silver medal at the Geneva International Exhibition of Inventions 2024.

Perioperative administration of 2% intravenous lidocaine does not appear to have any positive impact on gut function recovery in patients who undergo elective minimally invasive colon resection, according to a study.

Individuals undergoing colonoscopy find smartphone instructions to be as effective as traditional paper instructions for bowel preparation, reports a study.

Negative colonoscopy screening findings appear to be associated with lower colorectal cancer (CRC) incidence and mortality for 20 years, and as such, rescreening intervals may be extended beyond the currently recommended 10 years for people with a low-risk profile, according to a study.

New drug applications approved by US FDA as of 16-30 November 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.